High-dose chemotherapy and autologous hematopoietic stem cell transplantation: the lymphoma experience and its potential relevance to solid tumors.

Abstract:

:Lymphomas, which are frequently subdivided into Hodgkin's disease and non-Hodgkin's lymphoma, represent one of the more curable cancers that present as a solid tumor. Unfortunately, most patients cannot be cured with conventional chemotherapy, therefore new techniques have been developed including high-dose chemotherapy and autotransplantation. Non-Hodgkin's lymphoma was one of the first illnesses to be tested using the new methods and initial encouraging results in relapsed lymphoma led to the testing of high-dose chemotherapy with autotransplantation as a primary therapy for patients with lymphomas. Encouraging results have been obtained in several randomized trials. Studies of the treatment of lymphoma have identified several principles related to the application of autotransplantation, which may be relevant to other solid tumors. Autotransplantation is likely to be of benefit only when using active chemotherapeutic agents that can be escalated in dose and when myelosuppression is the dose-limiting toxicity. Chemotherapy-responsive tumors are obvious targets for autotransplantation, whereas chemotherapy-resistant tumors are unlikely to benefit. Other factors that should be taken into account when selecting patients for high-dose chemotherapy regimens include the extent of disease, preceding therapy and the performance status of the patient.

journal_name

Oncology

journal_title

Oncology

authors

Armitage JO

doi

10.1159/000012100

subject

Has Abstract

pub_date

2000-04-01 00:00:00

pages

198-206

issue

3

eissn

0030-2414

issn

1423-0232

pii

12100

journal_volume

58

pub_type

杂志文章,评审

相关文献

ONCOLOGY文献大全
  • Costs associated with capecitabine or 5-fluorouracil monotherapy after surgical resection in patients with colorectal cancer.

    abstract:OBJECTIVE:To compare chemotherapy-related and total medical costs among patients with colorectal cancer (CRC) receiving capecitabine or 5-fluorouracil (5-FU) monotherapy after surgical resection. METHODS:This retrospective, claim-based study utilized the Thomson Reuters Market Scan(R) databases to identify 1,396 CRC p...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000236048

    authors: Chu E,Shi N,Wei W,Bendell JC,Cartwright T

    更新日期:2009-01-01 00:00:00

  • Plasma thrombin-antithrombin complexes, latent coagulation disorders and metastatic spread in lung cancer: a longitudinal study.

    abstract::In patients affected with different tumours, disorders concerning clotting are frequently observed. The biological processes leading to coagulation are probably involved in the mechanisms of metastasis. We studied plasma levels of thrombin-antithrombin III complexes (TAT) in 90 patients affected with lung tumours subg...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227620

    authors: Tricerri A,Vangeli M,Errani AR,Guidi L,Canetta M,Vaccarino M,De Santis C,Ipsevich F,Salvati F,Bartoloni C

    更新日期:1996-11-01 00:00:00

  • Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.

    abstract:OBJECTIVE:The objective of this study was to evaluate the antitumor, survival, and adverse effects of hepatic arterial infusion chemotherapy using epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis. METHODS:The study population comprised 45 consecutive patients with advanced...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000112805

    authors: Ikeda M,Okusaka T,Ueno H,Morizane C,Iwasa S,Hagihara A,Kojima Y

    更新日期:2007-01-01 00:00:00

  • Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma.

    abstract::To establish appropriate indications for endoscopic treatment of submucosal invasive gastric carcinoma, we investigated clinicopathologic features and proliferating cell nuclear antigen (PCNA) expression at the deepest invasive portion of 192 differentiated submucosal invasive gastric carcinomas that had been surgical...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227486

    authors: Nishida T,Tanaka S,Haruma K,Yoshihara M,Sumii K,Kajiyama G

    更新日期:1995-07-01 00:00:00

  • Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features.

    abstract:BACKGROUND:There has been no clinically useful diagnostic or prognostic biomarker for renal cell carcinoma (RCC). Serum γ-glutamyltransferase (GGT) activity has been reported to be a prognostic marker for several types of cancer including RCC. Exosomes or small extracellular vesicles present in body fluids have potenti...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000508688

    authors: Horie K,Kawakami K,Fujita Y,Matsuda Y,Arai T,Suzui N,Miyazaki T,Koie T,Mizutani K,Ito M

    更新日期:2020-01-01 00:00:00

  • Effect of 1(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) on Sato lung carcinoma (SLC). Preliminary result of immunochemotherapy for SLC by combination of ACNU and Propionibacterium acnes.

    abstract::ACNU was highly effective for Sato lung carcinoma transplanted intravenously or intramuscularly by using a large single dose, and the cytotoxic action of ACNU for SLC showed clear dependence upon tumor size. Nonspecific activation of host-defence mechanism by Propionibacterium acnes contributed to the suppression for ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225309

    authors: Saijo N,Niitani H,Irimajiri N,Chikama M

    更新日期:1979-01-01 00:00:00

  • Concurrent chemoradiotherapy with a novel fluoropyrimidine, S-1, and cisplatin for locally advanced esophageal cancer: long-term results of a phase II trial.

    abstract:OBJECTIVES:A phase II study was performed to investigate the safety and efficacy of concurrent chemoradiotherapy (CCRT) combined with an orally active fluoropyrimidine, S-1, plus cisplatin for locally advanced esophageal cancer (LAEC). METHODS:CCRT comprised 2 courses, a 30-Gy radiotherapy over 3 weeks plus daily oral...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000348383

    authors: Iwase H,Shimada M,Tsuzuki T,Hirashima N,Okeya M,Hibino Y,Ryuge N,Yokoi M,Kida Y,Kuno T,Tanaka Y,Kato B,Esaki M,Urata N,Kato E

    更新日期:2013-01-01 00:00:00

  • Clinical staging of adult non-Hodgkin's lymphoma.

    abstract::In this study an attempt is made to propose a working clinical classification and staging of adult non-Hodgkin's lymphoma (NHL) which brings out both primary site and extent of disease. Unlike childhood NHL, where histopathology is uniformly of unfavourable type, this clinical staging system seems to have a prognostic...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226843

    authors: Lalitha N

    更新日期:1990-01-01 00:00:00

  • Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression.

    abstract:OBJECTIVE:Anti-p53 levels detected by different methods were compared in a predefined group of patients with breast cancer and correlated with p53 antigen expression in the corresponding tumors. METHODS:P53 autoantibodies were investigated in 165 patients with primary breast cancer using ELISAs with recombinant or nat...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000065472

    authors: Volkmann M,Sinn HP,Gaugel D,Frey M,Hajjar Y,Ludwig J,Hänsel S,Bastert G,Wallwiener D,Fiehn W,Zentgraf H,Huober J

    更新日期:2002-01-01 00:00:00

  • Overexpression of tyrosine kinase B protein as a predictor for distant metastases and prognosis in gastric carcinoma.

    abstract:OBJECTIVE:Tyrosine kinase B (TrkB) is associated with aggressive behavior and poor prognosis in various cancers. Here we examined the association between TrkB expression and distant metastases/prognosis in gastric carcinoma (GC). PATIENTS AND METHODS:We analyzed TrkB expression in 161 GC patients by immunohistochemist...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000151615

    authors: Zhang Y,Fujiwara Y,Doki Y,Takiguchi S,Yasuda T,Miyata H,Yamazaki M,Ngan CY,Yamamoto H,Ma Q,Monden M

    更新日期:2008-01-01 00:00:00

  • Intracavitary oxytetracycline in malignant pericardial tamponade.

    abstract::We started a treatment trial for malignant pericardial tamponade with intracavitary oxytetracycline, 500-1,000 mg/day, administered via an indwelling pericardial cannula after extraction of as much pericardial fluid as possible. This procedure was repeated every 24 h for 6 consecutive days or until no more fluid could...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227098

    authors: Grau JJ,Estapé J,Palombo H,Roca M,Daniels M,Tarragó E,Viñolas N

    更新日期:1992-01-01 00:00:00

  • Matched-pair analysis in patients with advanced oropharyngeal cancer: surgery versus concurrent chemoradiotherapy.

    abstract:OBJECTIVE:The current study aimed to compare the therapeutic outcomes of surgery with those of chemoradiation for patients with advanced oropharyngeal cancer (OPC). METHODS:The data for 523 patients with previously untreated OPC were obtained from 12 institutions belonging to the Head and Neck Cancer Study Group in th...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000346908

    authors: Kano S,Homma A,Hayashi R,Kawabata K,Yoshino K,Iwae S,Hasegawa Y,Nibu K,Kato T,Shiga K,Matsuura K,Monden N,Fujii M

    更新日期:2013-01-01 00:00:00

  • Results with CCNU in resistant Hodgkin's and non-Hodgkin's lymphoma.

    abstract::72 patients with advanced malignant lymphoma resistant to standard chemotherapy were treated with 1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea (CCNU) at 130 mg/m2 orally every six weeks. Objective responses were noted in 13 of 39 evaluable patients with Hodgkin's disease, three of 15 patients with lymphocytic lymphoma...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225162

    authors: Stolinsky DC,Solomon J,Weiner JM,Bateman JR

    更新日期:1976-01-01 00:00:00

  • Methyl-CCNU in malignant melanoma--a divided dose schedule of administration.

    abstract::Methyl-CCNU (NSC-95441) was administered to patients with malignant melanoma in a split dose schedule. Nausea and vomiting were eliminated as clinical problems during therapy. Response rate to the drug seemed somewhat lower than the average of three previously reported disease-oriented phase II trials, though the diff...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225178

    authors: Wittes RE,Hong WK,Gatchell L,Krakoff IH,Golbey RB

    更新日期:1977-01-01 00:00:00

  • Prognostic relevance of circulating tumor cells in metastatic uveal melanoma.

    abstract:OBJECTIVE:Uveal melanoma primarily metastasizes hematogenously with metastases often confined to the liver. The aim of this study was to investigate the presence of circulating tumor cells (CTC) in patients with metastatic disease as a marker for systemic disease and to determine their prognostic relevance. METHODS:Bl...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000328283

    authors: Schuster R,Bechrakis NE,Stroux A,Busse A,Schmittel A,Thiel E,Foerster MH,Keilholz U

    更新日期:2011-01-01 00:00:00

  • Evaluation of ART Scores for Repeated Transarterial Chemoembolization in Japanese Patients with Hepatocellular Carcinoma.

    abstract:OBJECTIVE:Transarterial chemoembolization (TACE) is recommended as a first-line therapy for hepatocellular carcinoma (HCC) patients ineligible for curative therapy and without portal invasion. The Assessment for Retreatment with TACE (ART) scoring system was recently proposed for identifying patients who would not show...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000440625

    authors: Arizumi T,Ueshima K,Iwanishi M,Minami T,Chishina H,Kono M,Takita M,Kitai S,Inoue T,Yada N,Hagiwara S,Ida H,Minami Y,Sakurai T,Nishida N,Kitano M,Kudo M

    更新日期:2015-01-01 00:00:00

  • Expression of DCC protein in colorectal tumors and its relationship to tumor progression and metastasis.

    abstract::A loss of heterozygosity (LOH) at the DCC gene locus was detected in colorectal tumors, and this LOH might be related to metastasis. The aim of this study was to determine DCC protein expression in colorectal cancer and to evaluate its prognostic value. Allelic loss of the DCC locus was observed in 16 of the 23 patien...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011954

    authors: Saito M,Yamaguchi A,Goi T,Tsuchiyama T,Nakagawara G,Urano T,Shiku H,Furukawa K

    更新日期:1999-01-01 00:00:00

  • Clear cell renal cell carcinoma associated with bilateral atypical acute posterior multifocal placoid pigment epitheliopathy.

    abstract:BACKGROUND/OBJECTIVE:Clear cell renal cell carcinoma (CCRCC) is a malignant neoplasm frequently associated with an increase in circulating immune complexes (CIC). Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is a disease involving the chorioretinal structures of the eye, and it is commonly observe...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000079505

    authors: Parmeggiani F,Costagliola C,D'Angelo S,Incorvaia C,Perri P,Sebastiani A

    更新日期:2004-01-01 00:00:00

  • Activities of organ characteristic enzymes and noradrenaline and glycogen contents in the Albert hepatoma of C57BL mice.

    abstract::Further biochemical characterization of the Albert hepatoma has been performed. The following results were obtained: In spite of often repeated transplantations and a medium growth rate, the Albert hepatoma does still contain organ-characteristic enzymes. We have found significant activities of glucokinase, glucose-6-...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225357

    authors: Sydow G

    更新日期:1979-01-01 00:00:00

  • Attenuation by the GABA receptor agonist baclofen of experimental carcinogenesis in rat colon by azoxymethane.

    abstract::The effects of the gamma-amino-n-butyric acid (GABA)A receptor agonist muscimol, and the GABAB receptor agonist baclofen, on colon carcinogenesis induced by azoxymethane in Wistar rats were tested. Administration of either muscimol or baclofen had no influence on the incidence of colon tumors at week 30. However, almo...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227048

    authors: Tatsuta M,Iishi H,Baba M,Taniguchi H

    更新日期:1992-01-01 00:00:00

  • A phase II trial of vindesine in hepatocellular cancer.

    abstract::Sixteen patients with histologically confirmed inoperable hepatocellular carcinoma were treated with vindesine 3 mg/m2 i.v. weekly. Anemia, leukopenia and neuritis were documented but no severe or life-threatening toxicity was seen. There were no objective responses among the 14 evaluable patients. Eight had a no chan...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227434

    authors: Falkson G,Burger W

    更新日期:1995-01-01 00:00:00

  • Hyperpyrexia, allergic-type response and death occurring with low-dose bleomycin administration.

    abstract::This is a case report of hyperpyrexia, shock and death following initial injection of low-dose bleomycin (7.5 units) for a poorly differentiated metastatic carcinoma. Premedication with high-dose dexamethasone and acetaminophen did not abort the reaction. A review of the literature uncovered one nearly fatal reaction ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225462

    authors: Levy RL,Chiarillo S

    更新日期:1980-01-01 00:00:00

  • Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study.

    abstract::The encouraging results that have been reported for cisplatin combination chemotherapy in a minority of patients with cancer of unknown primary (CUP) together with the previously shown equal activity of carboplatin in this setting, prompted us to investigate the effectiveness of a carboplatin-containing regimen in a p...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000011890

    authors: Briasoulis E,Tsavaris N,Fountzilas G,Athanasiadis A,Kosmidis P,Bafaloukos D,Skarlos D,Samantas E,Pavlidis N

    更新日期:1998-09-01 00:00:00

  • Lipid metabolism and liver disease in hepatitis C viral infection.

    abstract::Persistent infection with hepatitis C virus (HCV) is a major risk toward development of hepatocellular carcinoma. A number of transgenic mouse lines carrying the cDNA of HCV genome have been established and evaluated in the study of HCV pathogenesis. Among those, the studies using transgenic mouse lines that carry the...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000315226

    authors: Koike K,Tsutsumi T,Yotsuyanagi H,Moriya K

    更新日期:2010-07-01 00:00:00

  • Epidermal Growth Factor Potentiates Migration of MDA-MB 231 Breast Cancer Cells by Increasing NaV1.5 Channel Expression.

    abstract:INTRODUCTION:Breast cancer is one of the leading causes of death worldwide and is the result of dysregulation of various signaling pathways in mammary epithelial cells. The mortality rate in patients suffering from breast cancer is high because the tumor cells have a prominent invasive capacity towards the surrounding ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000501802

    authors: González-González L,González-Ramírez R,Flores A,Avelino-Cruz JE,Felix R,Monjaraz E

    更新日期:2019-01-01 00:00:00

  • Bone scintigrams: their clinical usefulness in patients with breast carcinoma.

    abstract::A comparison of bone scintigrams and roentgenographic skeletal surveys, obtained on 170 patients with breast carcinoma, was made to evaluate the diagnostic efficacy of these techniques in detecting metastatic bone lesions. The bone scans were abnormal in 81 patients, while the roentgenograms were abnormal in only 51. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225325

    authors: Joo KG,Parthasarathy KL,Bakshi SP,Rosner D

    更新日期:1979-01-01 00:00:00

  • Frequent loss of heterozygosity but rare microsatellite instability in oesophageal cancer in Japanese and Chinese patients.

    abstract::Reported frequencies for microsatellite instability (MSI) in oesophageal cancer differ widely in the literature, perhaps due to the high incidence of loss of heterozygosity (LOH) in this cancer. Using high-resolution fluorescent microsatellite analysis (HRFMA), we analysed microsatellite alterations in detail in 50 Ja...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000081002

    authors: Araki K,Wang B,Miyashita K,Cui Q,Ohno S,Baba H,Zhang RG,Sugimachi K,Maehara Y,Oda S

    更新日期:2004-01-01 00:00:00

  • Three primary cancers in different organs.

    abstract::In a registry of 24,105 cancers, 15 patients were found to have three primary cancers in different organs. Decreasing time intervals between sequential diagnoses and then death were noted. Occurrence and sequence of cancer sites appeared to be random. Stage of second and third cancers tended, on the average, to be mor...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225051

    authors: Holmes FF,Cole PA Jr

    更新日期:1975-01-01 00:00:00

  • Differences in cellular proteins between high and low metastatic potential sublines from the methylcholanthrene-induced rat fibrosarcoma cell line.

    abstract::The purpose of the present study was to determine with two-dimensional electrophoresis whether two sublines (high and low metastatic potential to lymph nodes) of rat fibrosarcoma induced by methylcholanthrene have differences in cellular proteins. The high metastatic potential subline had a specific protein in the pro...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227028

    authors: Minato K,Manabe T,Okuyama N,Sasaki Y,Nakagawa K,Saijo N

    更新日期:1992-01-01 00:00:00

  • Elliptinium acetate in metastatic breast cancer--a phase II study.

    abstract::Thirty-five patients with metastatic breast cancer who had received one or two prior chemotherapeutic regimens were treated with elliptinium acetate at a dose of 80 mg/m2 for 3 days every 3 weeks. Of the 33 patients evaluable for response, 1 patient achieved complete remission, 4 achieved partial responses (15% overal...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226797

    authors: Buzdar AU,Hortobagyi GN,Esparza LT,Holmes FA,Ro JS,Fraschini G,Lichtiger B

    更新日期:1990-01-01 00:00:00